This page in English

Tetyana Tegnebratt

Anknuten

Besöksadress : Neuroradiologiska Kliniken, R3:00, Karolinska Universitetssjukhuset Solna 171 76 Stockholm
Postadress : Institutionen för klinisk neurovetenskap (CNS), K8, Neuro Flodmark/Holmin, Neuroradiologiska Kliniken, R3:00, Karolinska Universitetssjukhuset Solna 171 76 Stockholm
Leveransadress : Neuroradiologiska Kliniken, R3:00, Karolinska Universitetssjukhuset Solna 171 76 Stockholm

Publikationer

Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake
Cheng Q, Wållberg H, Grafström J, Lu L, Thorell Jo, Hägg Olofsson M, et al
EJNMMI research 2016;6(1):58-

Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches
Tegnebratt T, Ruge E, Bader S, Ishii N, Aida S, Yoshimura Y, et al
EJNMMI research 2014;4(1):34-

Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ
Samén E, Lu L, Mulder J, Thorell Jo, Damberg P, Tegnebratt T, et al
EJNMMI research 2014;4(1):17-

[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models
Tegnebratt T, Lu L, Lee L, Meresse V, Tessier J, Ishii N, et al
EJNMMI research 2013;3(1):67-

Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats
Samén E, Arnberg F, Lu L, Olofsson Mh, Tegnebratt T, Thorell Jo, et al
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(10):1804-11

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells
Buentke E, Nordstrom A, Lin H, Bjorklund Ac, Laane E, Harada M, et al
BLOOD CANCER JOURNAL 2011;:e31-

Angiomotin-Like Protein 1 Controls Endothelial Polarity and Junction Stability During Sprouting Angiogenesis
Zheng Yj, Vertuani S, Nystrom S, Audebert S, Meijer I, Tegnebratt T, et al
CIRCULATION RESEARCH 2009;105(3):260-70

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2009;106(9):3414-9

Horizontal transfer of tumor DNA to endothelial cells in vivo
Ehnfors J, Kost-alimova M, Persson Nl, Bergsmedh A, Castro J, Levchenko-tegnebratt T, et al
CELL DEATH AND DIFFERENTIATION 2009;16(5):749-57

Synthesis and preclinical evaluation of [C-11]PAQ as a PET imaging tracer for VEGFR-2
Samen E, Thorell Jo, Lu L, Tegnebratt T, Holmgren L, Stone-elander S
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2009;36(8):1283-95

Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo
Levchenko T, Veitonmaeki N, Lundkvist A, Gerhardt H, Ming Y, Berggren K, et al
FASEB JOURNAL 2008;22(3):880-9

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth
Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmaki N, Levchenko T, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2006;103(24):9208-13

Angiomotin expression promotes hemangioendothelioma invasion
Levchenko T, Bratt A, Arbiser Jl, Holmgren L
ONCOGENE 2004;23(7):1469-73

Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin
Levchenko T, Aase K, Troyanovsky B, Bratt A, Holmgren L
JOURNAL OF CELL SCIENCE 2003;116(18):3803-10

Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation
Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L
JOURNAL OF CELL BIOLOGY 2001;152(6):1247-54

Visa alla publikationer